FoxHollow Integration Problems Plague ev3 In First Quarter
Endovascular device firm ev3's failure to meet first-quarter 2008 revenue targets is being blamed on unexpected challenges in assimilating the FoxHollow Technologies sales force
Endovascular device firm ev3's failure to meet first-quarter 2008 revenue targets is being blamed on unexpected challenges in assimilating the FoxHollow Technologies sales force